Literature DB >> 8635088

Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients.

F Trevisani1, P E D'Intino, G L Grazi, P Caraceni, A Gasbarrini, A Colantoni, G F Stefanini, A Mazziotti, G Gozzetti, G Gasbarrini, M Bernardi.   

Abstract

BACKGROUND: It is not known whether putative etiologic factors and clinical and pathological features of hepatocellular carcinoma (HCC) differ between young adult and older white patients.
METHODS: We examined the characteristics of 498 consecutive patients with HCC age < 50 years (Group 1: 54 patients) and age > or = 50 (Group 2: 444 patients), an age beyond which the tumor occurrence rate briskly increases.
RESULTS: Demographic characteristics, alcohol and coffee intake, and cigarette smoking did not differ between the two groups. Group 1 had a greater prevalence of the hepatitis B surface antigen (HBsAg) carriers (P = 0.006), while the prevalence of either past hepatitis B virus infection (P = 0.008) or antivirus C antibodies (P = 0.016) was higher in Group 2. The lack of both hepatitis B and C virus serologic markers was more common in Group 1 (P = 0.018). In these patients, HCC was less frequently superimposed on cirrhosis (P = 0.002) and was more advanced at the time of diagnosis. In fact, despite a better histologic differentiation grade (P = 0.019), monofocal (solitary and massive) tumors were larger (P = 0.012), small lesions (< or = 5 cm) less frequent (P = 0.028), and either diffuse (P < 0.001) or massive (P = 0.011) types more common. An elevation of serum alpha-fetoprotein was less frequent in group 1 (P = 0.016), but this difference disappeared when the "diagnostic" cut-off of 400 ng/mL was considered. Albeit the prevalence of presenting symptoms did not significantly differ between the two groups, the clinical stage was more advanced in young patients (P = 0.004). The 9-year cumulative rate of survival was similar in the 2 groups.
CONCLUSIONS: An early exposure to the virus and/or an accelerated hepatocarcinogenesis in HBsAg carriers can be inferred. Moreover, in the period of life at low risk for hepatoma: (1) the impact of nonalcoholic chemical carcinogenesis seems to be greater; (2) the tumor occurrence is less dependent on cirrhosis development; (3) although histologically better differentiated, the neoplasm is more advanced at the time of diagnosis; and (4) the long term survival is similar to that of the patients age 50 years or older.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635088     DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2223::AID-CNCR7>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Clear Cell Cancer of the Liver Presenting with Pathological Humeral Fracture: a Case Report.

Authors:  Mina S Hanna; Debasish Das
Journal:  J Gastrointest Cancer       Date:  2015-12

2.  Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey.

Authors:  Mustafa Sunbul; Hakan Leblebicioglu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

3.  Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.

Authors:  L Benvegnù; F Noventa; E Bernardinello; P Pontisso; A Gatta; A Alberti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

4.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

5.  Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma.

Authors:  Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 6.  Stem cell origins and animal models of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; M Behnan Sahin; Erik N K Cressman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

7.  Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.

Authors:  Hoi-Hung Chan; Tian-Huei Chu; Hsin-Fan Chien; Cheuk-Kwan Sun; E-Ming Wang; Huay-Ben Pan; Hsiao-Mei Kuo; Tsung-Hui Hu; Kwok-Hung Lai; Jiin-Tsuey Cheng; Ming-Hong Tai
Journal:  BMC Gastroenterol       Date:  2010-07-22       Impact factor: 3.067

8.  Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe.

Authors:  Nyasha Chin'ombe; Evans Chavhunduka; Hilda T Matarira
Journal:  Infect Agent Cancer       Date:  2009-10-08       Impact factor: 2.965

9.  Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients.

Authors:  Xin-Sen Xu; Wei Chen; Run-Chen Miao; Yan-Yan Zhou; Zhi-Xin Wang; Ling-Qiang Zhang; Kai Qu; Qing Pang; Rui-Tao Wang; Chang Liu
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

10.  Molecular characteristics of hepatocellular carcinomas from different age groups.

Authors:  Celina Ang; Anthony Shields; Joanne Xiu; Zoran Gatalica; Sandeep Reddy; Mohamed E Salem; Carol Farhangfar; Jimmy Hwang; Igor Astsaturov; John L Marshall
Journal:  Oncotarget       Date:  2017-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.